Evidence for the etiology of autism spectrum disorders (ASDs) has consistently pointed to a strong genetic component complicated by substantial locus heterogeneity 1,2 . We sequenced the exomes of 20 individuals with sporadic ASD (cases) and their parents, reasoning that these families would be enriched for de novo mutations of major effect. We identified 21 de novo mutations, 11 of which were protein altering. Protein-altering mutations were significantly enriched for changes at highly conserved residues. We identified potentially causative de novo events in 4 out of 20 probands, particularly among more severely affected individuals, in FOXP1, GRIN2B, SCN1A and LAMC3. In the FOXP1 mutation carrier, we also observed a rare inherited CNTNAP2 missense variant, and we provide functional support for a multi-hit model for disease risk 3 . Our results show that trio-based exome sequencing is a powerful approach for identifying new candidate genes for ASDs and suggest that de novo mutations may contribute substantially to the genetic etiology of ASDs.
ASDs are characterized by pervasive impairment in language, com munication and social reciprocity and restricted interests or stereo typed behaviors 1 . Several new candidate loci for ASDs have recently been identified using genomewide approaches that discover indi vidually rare events of major effect 2 . A number of genetic syndromes with features of the ASD phenotype, collectively referred to as syn dromic autism, have also been described 4 . Despite this progress, the genetic basis for the vast majority of cases remains unknown. Several observations support the hypothesis that the genetic basis for ASDs in sporadic cases may differ from that of families with multiple affected individuals, with the former being more likely to result from de novo mutation events rather than inherited variants 1, [5] [6] [7] . In this study, we sequenced the proteincoding regions of the genome (the exome) 8 to test the hypothesis that de novo proteinaltering muta tions contribute substantially to the genetic basis of sporadic ASDs.
In contrast with arraybased analysis of large de novo copy number variants (CNVs), this approach has greater potential to implicate single genes in ASDs.
We selected 20 trios with an idiopathic ASD, each consistent with a sporadic ASD based on clinical evaluations ( Supplementary Table 1 ), pedigree structure, familial phenotypic evaluation, family history and/or elevated parental age. Each family was initially screened by array comparative genomic hybridization (CGH) using a customized microarray 9 . We identified no large (>250 kb) de novo CNVs but did identify a maternally inherited deletion (~350 kb) at 15q11.2 in one family (Supplementary Fig. 1 ). This deletion has been associated with increased risk for epilepsy 10 and schizophrenia 11, 12 but has not been considered causal for autism.
Similar to researchers from a previous study 13 , who reported exome sequencing on ten parentchild trios with sporadic cases of moder ate to severe intellectual disability, we performed exome sequencing on each of the 60 individuals separately by subjecting wholeblood derived genomic DNA to insolution hybrid capture and Illumina sequencing (Online Methods). We obtained sufficient coverage to call variants for ~90% of the primary target (26.4 Mb) ( Table 1) . Genotype concordance with SNP microarray data was high (99.7%) ( Supplementary Table 2 ), and on average, 96% of proband variant sites were also called in both parents ( Supplementary Table 3 ). Given the expected rarity of true de novo events in the targeted exome (<1 per trio) ( Supplementary Table 4 ) 14 , we reasoned that most apparently de novo variants would result from under calling in parents or sys tematic false positive calls in the proband. We therefore filtered vari ants previously observed in the dbSNP database, 1000 Genomes Pilot Project data 15 and 1,490 other exomes sequenced at the University of Washington (Supplementary Fig. 2 ). We performed Sanger sequenc ing on the remaining de novo candidates (<5 per trio), validating 18 events within coding sequence and three additional events mapping to 3′ untranslated regions ( Table 2) . A list of predicted variant sites within these genes from the 1000 Genomes Pilot Project data 15 is provided for comparison ( Supplementary Table 5 ).
l e t t e r s
We observed subtle differences with respect to mutation rate and characteristics when compared to the previous study 13 (Supplementary Note). The overall proteincoding de novo rate (0.9 events per trio) was slightly higher than expected 14 (0.59 events per trio), suggesting that we identified the majority of the de novo events in these trios ( Supplementary Table 4 ). The transition to transver sion ratio was highly skewed (18:2), with eight transitions mapping to hypermutable CpG dinucleotides 14 . The proportion of synonymous events was higher than expected based on a neutral model and may reflect selection against embryonic lethal nonsynonymous variants. We successfully determined the parent of origin for seven events, six of which occurred on the paternal haplotype ( Table 2) . Notably, the eight probands with two or more validated de novo events cor responded to families with higher parental age (MannWhitney U, combined age, onesided P < 0.004).
Eleven of the 18 coding de novo events are predicted to alter pro tein function. Each of these mutations occurred in a different gene, precluding a statistical assessment for any specific locus despite their deleterious nature (for example, using PolyPhen2) 16 . We assessed whether proband de novo mutations were enriched in the aggregate for disruptive events by considering two independent quantitative measures: the nature of the aminoacid replacement (Grantham matrix score 17 ) and the degree of nucleotidelevel evolutionary conservation (Genomic Evolutionary Rate Profiling (GERP) 18, 19 ) ( Fig. 1a,b) . For comparison, we sequenced 20 exomes from unrelated ethnically matched controls (from HapMap) and applied the same filters to identify codingsequence mutations that were common or private to each of the samples. These control DNA samples were isolated from immortalized lymphoblasts; however, the counts of private variants in the cases and controls were highly similar, sug gesting that the contribution of new somatic events is likely minimal (Supplementary Fig. 3) .
We determined by simulation the expected mean GERP and Grantham distributions for ten randomly selected common or private control single nucleotide variants (SNVs) (Online Methods). When we compared the observed means of the ten de novo protein altering ASD proband variants to the distribution of common control SNVs (Fig. 1a) , they corresponded to more highly con served (GERP, P < 0.001) and disruptive amino acid mutations (Grantham, P = 0.015). If we limited the analysis to the private control SNVs, which serve as a proxy for evolutionarily young mutation events ( Fig. 1b) , we again found that the de novo events were at the right tail of these distributions. Only the mean GERP score, however, remained significant (GERP, P = 0.02; Grantham, P = 0.115). In total, these results suggest that these de novo muta tion sites are subjected to stronger selection and are likely to have functional impact.
We identified a subset of trios (4 out of 20) with disruptive de novo mutations that are potentially causative, including genes previously associated with autism, intellectual disability and epilepsy ( Table 2 and Supplementary Note). We examined the available clinical data for these four families and found that they were among the most severely affected individuals in our study based on intelligence quo tient (IQ) measures and on calibrated severity score 20 (CSS), which is largely independent from IQ and focuses specifically on autistic features, with a score of 10 being the most severe ( Fig. 1c,d) . For example, in proband 12681, we identified a singlebase substitution (IVS92A>G) at the canonical 3′ splice site of exon 10 in GRIN2B (encoding glutamate receptor, ionotropic, Nmethyl Daspartate 2B) ( Supplementary Fig. 4a,b ). This subject is severely affected (CSS 9), with evidence of early onset, possible regression and comorbidity for mild intellectual disability. Expression and association studies have suggested that glutamatergic neurotransmission may play a role in ASDs 4 . Recently, a study 21 described GRIN2A and GRIN2B as sites of recurrent de novo mutations in individuals with mild to moderate intellectual disability and/or epilepsy, suggesting variable expressivity. Our data suggest that de novo mutations in GRIN2B may also lead to an ASD presentation. 
Proband 12499 has a missense variant (p.Pro1894Leu) at a highly conserved position in SCN1A (encoding sodium channel, voltage gated, type I, alpha subunit) that is predicted to be functionally del eterious (Supplementary Fig. 4c ). This subject is severely affected (CSS 8), with evidence of early onset, possible regression, language delay, a diagnosis of epilepsy and mild intellectual disability. SCN1A was previously associated with epilepsy and has been suggested as an ASDs candidate gene 22, 23 , although limited screening has been conducted in idiopathic ASDs. Hundreds of diseaseassociated muta tions have been described in epilepsy, and typically individuals with de novo events show more severe phenotypes 24 . The proband also carries the maternally inherited 15q11.2 deletion that increases the risk for epilepsy 10 .
Proband 11666 has a missense variant (p.Asp399Gly) at a highly conserved position within the second laminintype epidermal growth factorlike domain of LAMC3 (encoding laminin, gamma 3) that is predicted to be functionally deleterious ( Supplementary Fig. 4d ). This subject is severely affected (CSS 10), with evidence of early onset and moderate intellectual disability. LAMC3 is not known to be involved in neuronal development; however, human microarray data have shown expression in many areas of the cortex and limbic system 25 . Additional study is warranted, as laminins have structural similarities to the neurexin and contactinassociated families of pro teins, both of which have been associated with ASDs 2 .
The fourth example of a potentially causative mutation is a single base insertion in FOXP1 (encoding forkhead box P1) introducing a frameshift and premature stop codon (p.Ala339SerfsX4) in proband 12817 (Fig. 1e) . This subject is severely affected (CSS 8), with evidence for regression, language delay and comorbidity for moderate intel lectual disability and nonfebrile seizures. Recently, rare occurrences of large de novo deletions and a nonsense variant disrupting FOXP1 were reported in individuals with mild to moderate intellectual dis ability and language defects, with or without ASD features 26, 27 . FOXP1 encodes a member of the forkheadbox family of transcription factors and is closely related to FOXP2, a gene implicated in rare monogenic forms of speech and language disorder [28] [29] [30] [31] . Functional evidence of heterodimer formation and overlapping neural expression patterns suggests that FOXP1 and FOXP2 can coregulate gene expression in the brain 32, 33 . We assessed relative levels of the mutant transcript in probandderived lymphoblasts and found strong evidence for nonsensemediated decay (NMD) (Supplementary Fig. 5a ). HEK293T cellbased functional assays further showed that, if translated, the protein would be truncated and mislocalized from the nucleus to the cytoplasm, similar to results obtained with FOXP2 mutations 31 (Supplementary Fig. 5b,c) .
Remarkably, in addition to the FOXP1 mutation, proband 12817 also carried an inherited missense variant (p.His275Arg) at a highly conserved position in CNTNAP2 (encoding contactin associated proteinlike 2) that is predicted to be functionally deleterious. This variant is likely to be extremely rare or private, as it was not observed in 942 previously sequenced controls 34 or in 1,490 other exomes. CNTNAP2 is directly downregulated by FOXP2 (ref. 35 ) and has been independently associated with ASD and specific language impair ment [34] [35] [36] [37] . In HEK293T cells, we found that wildtype FOXP1 sig nificantly reduced expression of CNTNAP2 (P = 0.0005), whereas the truncated protein was associated with a threefold expression increase (P = 0.0056) (Supplementary Note and Supplementary  Fig. 5d ). Overall, we hypothesize that FOXP1 haploinsufficiency (caused by NMD), combined with dysfunction of FOXP1 mutant proteins that escape this process, may result in overexpression of CNTNAP2 protein, amplifying any deleterious effects of p.His275Arg in the proband.
Among the ~110 (85 SNVs and 25 indels) previously unreported inherited proteinaltering variants in each proband, we identified sev eral rare inherited variants in genes overlapping SFARI Gene 38 , a curated database of potential ASD candidate loci, but we saw no excessive l e t t e r s burden in cases relative to controls ( Supplementary Table 6 ).
Although the numbers of subjects from our pilot study are few, we did observe two cases with a notable de novo event and a potential inherited risk variant (12817.p1, FOXP1 and CNTNAP2; 12499.p1, SCN1A and 15q11.2 deletion), highlighting that in some sporadic families a multihit model may be playing a role 3 ( Supplementary  Table 7 ). In the future, this hypothesis could be further explored by comparing burden in a much larger number of affectedunaffected sibling pairs. The probands with the four potentially causative de novo events met strict criteria for a diagnosis of autistic disorder (Supplementary Note). Our finding of de novo events in genes that have also been disrupted in children with intellectual disability without ASD, intel lectual disability with ASD features or epilepsy provides further evidence that these genetic pathways may lead to a spectrum of neuro developmental outcomes depending on the genetic and environmen tal context 2, 4 . Recent data suggest that CNVs may also blur these lines, with diverse conditions all showing association to the same loci 2, 4 . Distinguishing primary from secondary effects will require a better understanding of the underlying biology and identification of interacting genetic and environmental factors within the pheno typic context of the family. The identification of de novo events along with disruptive inherited mutations underlying 'sporadic' ASDs has the potential to fundamentally transform our understanding of the genetic basis of autism.
URLs. SeattleSeq server, http://gvs.gs.washington.edu/SeattleSeqAnnotation/; Primer3, http://frodo.wi.mit.edu/primer3/.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. Accession numbers. Reference sequences are available from the NCBI CCDS database under the following accession codes: CNTNAP2, CCDS5889.1; FOXP1, CCDS2914.1; GRIN2B, CCDS8662.1; LAMC3, CCDS6938.1; SCN1A, CCDS33316.1. The raw sequence reads are available from the National Database for Autism Research under accession number NDARCOL0001878.
Note: Supplementary information is available on the Nature Genetics website.
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ASD samples. We examined 20 families where there was a single child with a diagnosis of ASD obtained from the Simons Simplex Collection (SSC) 39 (n = 19) and the Study of Autism Genetics Exploration (SAGE) (n = 1). We required subjects to have at least one unaffected sibling with no history of ASD or intellectual disability based on medical history and/or pedigree evaluation. Parents showed no signs of a broader autism phenotype based on Broad Autism Phenotype Questionnaire 40 (cutoff ≤ 3) and AdultSocial Responsiveness Scale (SRS) 41 (cutoff ≤ 40). Siblings were discordant for the SRS and VinelandII, with the unaffected sibling falling within the normal range.
Control exomes. Exome sequence data from 20 unrelated CEPH Utah samples of European ancestry were obtained from immortalized lymphoblast extracted genomic DNA and processed through the same variant calling pipeline.
Control simulation.
Proteinaltering control variants were randomly shuf fled, and ten were selected over 1,000 trials to build an expected distribution of common or rare events, computing the mean Grantham and GERP scores for each trial. Empirical P values were then calculated based on the number of trials in which the control mean was greater than the observed mean of the ten proband disruptive de novo variants.
Other control exomes. Variants were screened against exome calls from 1,490 samples to remove common variants and systematic artifacts. Samples were obtained from the NHLBI Lung Cohort Sequencing Project (n = 635), the NHLBI WHI Sequencing Project (n = 744), NIEHS SNPs (n = 87) and NHLBI/NHGRI SeattleSeq and NHGRI Next Generation Mendelian Genetics (n = 24).
Array CGH. We designed custom targeted arrays comprising 135,000 probes (Roche NimbleGen) with higher density probe coverage (mean probe spacing 2.5 kb) in genomic hotspots and a lower probe density in genomic backbone (with mean probe spacing of 38 kb). Microarray hybridization experiments and CNV analysis were performed as described previously 42, 43 using a single unaffected male reference (GM15724 from Coriell).
ASD exome library construction. Exome shotgun libraries were prepared as described previously 44 For barcode preps, five reactions were performed per sample, with each reac tion in a 50 µl volume with 10 µl of library as above, but for only 13 cycles. Reactions for each sample were pooled and bead purified. Family 13284 was also captured using a custom RefSeq solid state array (Agilent) as described 45 . Libraries were sequenced on an Illumina Genome Analyzer IIx according to the manufacturer's instructions for single or pairedend 76bp reads.
Estimating the expected mutation rate. We used mutation rates published by Lynch 14 , as he provides an estimate of substitution, insertion and deletion rates and is in close agreement with other recent estimates 15, 46 . We first calcu lated the number of callable bases in the first six completed trios that directly overlapped or were within 2 bp of the ends of the exon coordinates from the current hg18 build of the Consensus Coding Sequence (CCDS) project. This analysis yielded 22,546,796 coding and 523,843 splice bases covered in an average trio. Using the following haploid mutation rates (substitution rate of 1.28 × 10 −8 , deletion rate of 5.80 × 10 −10 and insertion rate of 2.00 × 10 −10 ), we calculated total number of substitution, indel and splicesite events. Finally, we separated the expected substitutions based their probably of causing an amino acid change under a random model of 25% synonymous, 71.25% missense and 3.75% nonsense substitutions.
Exome data analysis for SNVs and small indels. The exome definition was based on consensus coding sequence (CCDS 2009) of the human reference genome (build36). For BWA (0.5.6) 47 mapped reads, we removed reads with mapping scores of zero, incorrect or unmapped pairs and potential duplicates. Consensus genotypes were generated using SAMtools (0.1.7) 48 . Variant posi tions were then pulled and filtered using the samtools.pl varFilter (all defaults except, D 10000 and awk ′($3 = = "*"&&$6> = 50) || ($3! = "*"&&$6> = 20)′). Variants were then run through a custom pipeline, Haystack, to identify Mendelian errors. For SNVs, proband variants were filtered to 8× and con sensus or SNP quality 30 positions that were called in the entire trio. Possibly de novo events were then compared against 1,490 other exomes sequenced at University of Washington to remove systematic artifacts and rare population variants. Variants were then annotated using the SeattleSeq server (see URLs).
Possibly de novo events were manually inspected using the IGV browser 15 . Base pair positions where >10% of the parental reads were concordant with the putative de novo event were excluded. We found that approximately onethird of ontarget de novo calls mapped to exons within segmental duplications 49 and likely represent paralogous sequence variants from missing duplicated genes or variants of limited functional consequence 50 . For BWA called indels, variants were filtered to a high confidence set supported by at least 30% of the reads with a minimum of eight variant reads. Positions without an indel call or 8× and consensus or SNP quality 30 position in both parents were removed. Variants were then annotated using a custom script, compared to dbSNP129 and dbSNP130 and 1000 Genomes Pilot indels and manually inspected.
Exome data analysis for large indels and CNVs. We used a general split read-based combinatorial algorithm (E.K., C. Alkan, B.J.O., D.A.N. & E.E.E., unpublished data) to detect structural variation in the form of insertions, deletions and copy number variants ranging in length from 1 bp to 1 Mb. This method identifies oneend anchored placements using mrsFAST 51 alignments. The unmapped ends of the oneend anchored reads are split into pieces at the breakpoints of possible indels. Our method computes the exact breakpoints of these splits and aims to map them back to the reference exome efficiently. The final set of indels is reported based on these consistent split mappings around these events within basepair resolution.
De novo validation.
Possibly de novo variants were tested by designing custom primers with Primer3 (see URLs), performing standard PCR reactions using 10 ng of DNA from the proband, father, mother and for 19 out of 20 families an unaffected sibling, followed by Sanger sequencing.
Family 12817 complementary DNA (cDNA) analysis. Transformed live lymphoblast cell lines were obtained on the father, mother, proband and two siblings from family 12817. Cultures were grown as described 52 and split into two flasks, one of which was supplemented with 100 µg/ml of emetine (Sigma) to inhibit NMD 52 . After 7 h of incubation, total RNA was extracted using RNeasy Mini Kit (Qiagen). First strand cDNA was generated using Transcriptor High Fidelity cDNA Synthesis Kit (Roche). FOXP1 cDNA was amplified using standard PCR with primers spanning several exons and subjected to Sanger sequencing.
Functional characterization of FOXP1. Plasmids expressing fulllength FOXP2 and FOXP1, as well as FOXP2.R553H and the FOXP2.10+ were described elsewhere 31 . The FOXP1mut construct was directly synthesized by GenScript USA Inc. All constructs were expressed from the pcDNA4/ HisMax vector and were in frame with an Nterminal vectorencoded Xpress tag. The antiXpress mouse monoclonal antibody (Invitrogen) was used to detect protein expression of all FOXP constructs. βactin mouse monoclonal antibody (Sigma) was used as loading control. HEK293T cells were cultured as described 31 and transfected with either empty pcDNA4/ HisMax vector or with pcDNA4/HisMax FOXP constructs using Genejuice (Novagen) transfection reagent according to the manufacturer's instruc tions. Fortyeight hours after transfection, cells were either lysed and resolved by SDSPAGE or seeded on coverslips for immunofluorescence, as previously described 31 . For quantitative PCR, total RNA was isolated using an RNeasy Mini Kit (Qiagen) following the manufacturer's instructions 48 h post transfection. Five hundred nanograms total RNA was reverse transcribed using the Superscript III Reverse Transcriptase and random primers (Invitrogen). Quantitative realtime PCR was performed on an iQ5 (BioRad) ( Supplementary Table 9 ).
